Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201804003286743Not yet recruiting
Randomised trial of midazolam, clonidine, gabapentin and sevoflurane in Emergence agitation (EA) (4 arms), sponsored by sherif kamal arafa. Primary endpoint: Incidence of emergence agitation. Planned start Apr 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201804003286743.